MSB.AX

MESOBLAST FPO [MSB]
ASXAUDEQUITY Healthcare DELAYED
Last price
2.36
▼ 0.15 (5.98%)
MARKET ·

Price

Drag pan · Pinch zoom · Hold crosshair · pick a tool then drag to draw
Open
2.47
Prev close
2.51
Day high
2.48
Day low
2.34
Volume
3.44M
Market cap
$3.06B
P/E (TTM)
52W range
1.88 – 3.31

Trailing performance

Price return · vs SPY
Returnvs SPY
1W
+6.79% +8.2%
1M
+1.72% -2.0%
3M
+11.32% +8.2%
6M
+0.43% -10.6%
YTD
-13.24% -25.5%
1Y
-3.67% -23.7%
3Y
+465.70% +391.5%
5Y
+26.03%

Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.

Unusual options activity

Account required
Nothing crossed the thresholds in the expiries we scanned.
That is the normal state — most contracts trade well inside their existing open interest.
Free account required

Contracts trading at or above their open interest, ranked by notional and where the print landed.

Free account

5 more panels on MSB.AX open with an account.

Options chains and analytics, valuation ratios, insider filings, analyst targets and ownership. No card, no trial, nothing to cancel.

Insider net activity

6m · Form 4 rollup
Net shares
0
Net selling
Buy transactions
0
0 shares
Sell transactions
0
Net transactions
0
Buys less sells
Sell : buy shares
Not enough filings
Insider-held shares
467.43M
Total on file

Insider transactions

Account required
DateInsiderAction SharesValueHeld
Jul 17, 26
Itescu (Silviu)
Chief Executive Officer
EXERCISE 1.89M $1.90M Direct
Jan 9, 26
Cobley (Lyn Elizabeth)
Director (Non-Executive)
BUY 30.00K $64.16K Direct
Jan 9, 26
Rose (Eric)
Director (Non-Executive)
638.67K Direct
Jan 6, 26
Rose (Eric)
Director (Non-Executive)
1.28M Direct
Oct 21, 25
Burns (William)
Independent Vice Chairman Of The Board
EXERCISE 120.00K $101.96K Direct
Apr 29, 25
Cobley (Lyn Elizabeth)
Director (Non-Executive)
33.00K Direct
Feb 28, 25
Bell (Jane Catherine)
Deputy Chairman
BUY 79.05K $124.13K Direct
Feb 28, 25
Rose (Eric)
Director (Executive)
EXERCISE 548.85K $3.40K Direct
Feb 28, 25
Rose (Eric)
Director (Executive)
SELL 196.09K $303.84K Direct
Jan 16, 25
Rose (Eric)
Director (Executive)
303.10K Direct
Dec 13, 24
Rose (Eric)
Director (Executive)
OTHER 5.04M Direct
What this is, and what it is not

These are SEC Form 4 filings — officers, directors and 10% owners reporting their own trades in the company's stock. Filing is due within two business days of the transaction, so this lags reality by days, and the provider adds its own lag on top.

A sale is not automatically bearish. Executives sell on scheduled 10b5-1 plans, to cover tax on vesting equity, and to diversify. Purchases with cash are generally the more informative signal, and they are far rarer.

This does not include congressional or senate trading. That comes from STOCK Act disclosures filed with the Senate eFD system and the House Clerk, which this data source does not carry.

Free account required

Officer and director trades in their own stock, straight from Form 4 filings.

Insider holders

5 reporting
NameRelationShares heldLatest
Bell (Jane Catherine)
Deputy Chairman 622.49K Purchase
Burns (William)
Independent Vice Chairman Of The Board 226.25K Exercise
Cobley (Lyn Elizabeth)
Director (Non-Executive) 63.00K Purchase
Itescu (Silviu)
Chief Executive Officer 80.84M Exercise
Rose (Eric)
Director (Non-Executive) 6.75M Sale

Fundamentals

TTM · reported
Market cap$3.06B
Enterprise value$3.05B
Revenue (TTM)$65.38M
Gross profit$-23.23M
EBITDA$-64.34M
Net income$-94.37M
EPS (TTM)$-0.11
Free cash flow$-69.44M
Total cash$129.97M
Total debt$135.14M
Book value / share$0.63
Shares outstanding1.30B
Float836.76M
Short % of float
Dividend yield
Beta (5Y)0.81

Valuation & profitability ratios

Account required
Trailing P/E
Forward P/E48.28
PEG ratio0.13
Price / sales
Price / book3.73
EV / revenue46.59
EV / EBITDA-47.34
Gross margin-35.53%
Operating margin-55.16%
Profit margin-144.33%
Return on equity-18.22%
Return on assets-6.16%
Debt / equity23.52
Current ratio1.58
Free account required

Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.

Financial statements

As reported · 4 years · 5 quarters
Blank means not reported, not zero
Line item2025202420232022YoY
Total revenue $17.20M$5.90M$7.50M$10.21M +191.4%
Operating revenue $17.20M$5.90M$7.50M$10.21M +191.4%
Cost of revenue $5.13M$0$0
Gross profit $12.07M$5.90M$7.50M +104.5%
Research & development $34.81M$39.72M$52.82M$32.81M -12.4%
Selling, general & admin $39.31M$24.98M$27.48M$57.97M +57.4%
Total operating expense $74.51M$63.87M$76.79M$91.32M +16.7%
Operating income -$62.44M-$57.97M-$69.29M-$81.11M -7.7%
Net interest income -$19.00M-$18.83M-$18.61M-$17.29M -0.9%
Pre-tax income -$101.81M-$88.15M-$82.10M-$91.59M -15.5%
Tax provision $330.00K-$191.00K-$212.00K-$239.00K +272.8%
Net income -$102.14M-$87.96M-$81.89M-$91.35M -16.1%
Net income to common -$102.14M-$87.96M-$81.89M-$91.35M -16.1%
Basic EPS -0.08-0.09-0.11-13.38 +5.1%
Diluted EPS -0.08-0.09-0.11-13.38 +5.1%
EBIT -$80.06M-$67.49M-$62.66M-$74.30M -18.6%
EBITDA -$80.06M-$67.49M-$62.66M-$74.30M -18.6%
Basic shares 1.21B986.70M777.72M682.86M +22.4%
Diluted shares 1.21B986.70M777.72M682.86M +22.4%

Options analytics

Account required
Put / call volume
Put / call open interest
Positioning, not flow
Max pain
ATM implied vol
Nearest strike to spot
Skew (10% OTM)
Call volume
0
Contracts, this expiry
Put volume
0
Contracts, this expiry
Heaviest call OI
Heaviest put OI

Max pain is the strike at which the largest dollar value of open contracts expires worthless. It describes current positioning; it is not a forecast and it moves as open interest changes.

Free account required

Put/call ratios, max pain, implied volatility skew and where open interest is concentrated.

Earnings

History & consensus estimates
Forward consensus
PeriodEPSAnalystsRevenueGrowth
Current quarter $47.13M
Next quarter $52.28M
Current year -0.06 3 $180.87M +586.3%
Next year 0.05 4 $308.62M +70.6%

Analyst targets & ownership

Account required
Mean target$3.93
High target$4.71
Low target$3.00
Implied upside66.53%
Analyst count4
ConsensusNONE
Strong buy / Buy1 / 5
Hold0
Sell / Strong sell0 / 0
Held by insiders36.28%
Held by institutions16.91%
Institutions holding58
Free account required

Price targets, consensus spread, insider and institutional ownership.

Moving averages & technicals

Computed from 2Y daily closes
SMA 10
2.39
-1.05% from price
SMA 20
2.24
+5.17% from price
SMA 50
2.20
+7.11% from price
SMA 100
2.15
+9.72% from price
SMA 200
2.31
+2.19% from price
EMA 12
2.35
+0.44% from price
EMA 26
2.29
+3.10% from price
EMA 50
2.24
+5.57% from price
RSI (14)
53.5
Neutral
MACD (12,26,9)
0.06
Hist 0.02
ATR (14)
0.13
5.42% of price
Realised vol 30D
75.7%
Annualised
Bollinger upper
2.56
20, 2σ
Bollinger lower
1.93
20, 2σ
50 / 200 cross
Death
2.20 vs 2.31
Trend bias
Above 200
+2.19%

Options chain

Account required
ExpirySpot 2.36
Calls
StrikeLastBidAskVolOIIV
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
Puts
StrikeLastBidAskVolOIIV
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
Free account required

Every listed expiry, both sides of the book, with volume, open interest and implied volatility.

Risk profile

Daily returns · 1Y window
Beta vs SPY
0.69
Less volatile than market
Correlation to SPY
0.15
Largely independent
Realised vol 30D
75.7%
Annualised
Market vol 1Y
12.9%
SPY, annualised
Max drawdown 1Y
-38.6%
Peak to trough
Max drawdown 5Y
-86.6%
Peak to trough
ATR 14
0.13
5.42% of price
Beta (reported)
0.81
5Y monthly, from filing

PRIVATE STRATEGY · BY QUALIFICATION

The same data. A different seat.

The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.